{"basic_info": {"ticker": "300149", "exchange": "XSHE", "bloomberg_ticker": "300149 CH Equity", "name": "CHEMPARTNER PHARMATECH CO-A", "industry": "Biotechnology", "name_chinese_simplified": "睿智医药", "period": "2020", "market_value": 7036858880, "total_income": 670228150, "ccy": "人民币元", "shariah_compliance_summary": "non-compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 667352012, "business_income_over_total_income": 0.9957087179940145}, {"shariah_compliance": "unknown", "income": 2876136, "business_income_over_total_income": 0.004291279021927085}], "details": [{"business_activity_cn": "医药研发服务及生产外包", "business_activity_en": "Pharmaceutical research and development services and outsourcing", "income": 522630740, "business_income_over_total_income": 0.7797803479307756, "shariah_compliance": "compliant"}, {"business_activity_cn": "微生态营养制剂", "business_activity_en": "Probiotics nutritional formulation", "income": 144721272, "business_income_over_total_income": 0.21592837006323892, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他业务", "business_activity_en": "Other business", "income": 2492192, "business_income_over_total_income": 0.003718423345841263, "shariah_compliance": "unknown"}, {"business_activity_cn": "合计特别调整", "business_activity_en": "Total special adjustments", "income": 383944, "business_income_over_total_income": 0.0005728556760858225, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.20611489325070678, "shariah_compliance": "non-compliant", "amount_over_market_value": 0.20611489325070678}]}